Authors:
RAUT S
DIGIAMBATTISTA M
BEVAN SA
HUBBARD AR
BARROWCLIFFE TW
LAUB R
Citation: S. Raut et al., MODIFICATION OF FACTOR-VIII IN THERAPEUTIC CONCENTRATES AFTER VIRUS INACTIVATION BY SOLVENT-DETERGENT AND PASTEURIZATION, Thrombosis and haemostasis, 80(4), 1998, pp. 624-631
Citation: M. Digiambattista et al., DESIGN AND IMMUNOREACTIVITY OF SYNTHETIC PEPTIDES OF HUMAN FACTOR-VIII, Thrombosis and haemostasis, 1997, pp. 2076-2076
Authors:
DIGIAMBATTISTA M
BAELDEN MC
HANSSENS S
LAUB R
Citation: M. Digiambattista et al., SENSITIVE WESTERN BLOTTING METHOD FOR MONITORING FVIII DEGRADATION INFVIII CONCENTRATES, Thrombosis and haemostasis, 1997, pp. 2089-2089
Authors:
DEWAEL L
DIGIAMBATTISTA M
WATTIEZ R
BAELDEN MC
BRANCKAERT T
LAUB R
Citation: L. Dewael et al., BIOCHEMICAL-PROPERTIES OF A S D AND SEVERE DRY HEAT-TREATED FVIII CONCENTRATE/, Thrombosis and haemostasis, 1997, pp. 2094-2094
Authors:
BARROWCLIFFE TW
DIGIAMBATTISTA M
RAUT S
BEVAN SA
HUBBARD AR
LAUB R
Citation: Tw. Barrowcliffe et al., MODIFICATION OF FVIII IN THERAPEUTIC CONCENTRATES AFTER VIRUS INACTIVATION BY SOLVENT-DETERGENT AND PASTEURIZATION, Thrombosis and haemostasis, 1997, pp. 2354-2354
Authors:
LAUB R
DIGIAMBATTISTA M
FONDU P
BRACKMANN HH
LENK H
SCANDELLA D
Citation: R. Laub et al., RESTRICTED EPITOPE SPECIFICITY OF FACTOR-VIII INHIBITORS WHICH APPEARED IN PREVIOUSLY TREATED HEMOPHILIACS AFTER INFUSION WITH OCTAVI SD PLUS, Thrombosis and haemostasis, 1997, pp. 2409-2409
Authors:
PEERLINCK K
ARNOUT J
DIGIAMBATTISTA M
GILLES JG
LAUB R
JACQUEMIN M
SAINTREMY JMR
VERMYLEN J
Citation: K. Peerlinck et al., FACTOR-VIII INHIBITORS IN PREVIOUSLY TREATED HEMOPHILIA-A PATIENTS WITH A DOUBLE VIRUS-INACTIVATED PLASMA-DERIVED FACTOR-VIII CONCENTRATE, Thrombosis and haemostasis, 77(1), 1997, pp. 80-86
Authors:
GILLES JG
DIGIAMBATTISTA M
LAUB R
SAINTREMY JMR
Citation: Jg. Gilles et al., HEATING LYOPHILIZED FACTOR-VIII DOES NOT ALTER ITS RECOGNITION BY SPECIFIC ANTIBODIES, Vox sanguinis, 73(1), 1997, pp. 16-23
Authors:
NYS M
LAUB R
DAMAS P
SONDAG D
GOETHALS T
JAMAER D
JOASSIN L
LAMY M
Citation: M. Nys et al., SCREENING AND CHARACTERIZATION OF SPECIFIC ANTILIPOPOLYSACCHARIDE ANTIBODIES IN BELGIAN BLOOD-DONORS BY ENZYME-LINKED IMMUNOSORBENT ASSAYS, European journal of clinical investigation, 26(12), 1996, pp. 1134-1142
Citation: R. Laub et G. Stingl, NAIVE VERSUS PREACTIVATED T-CELLS EXHIBIT DIFFERENT SUSCEPTIBILITY TOIL-1-BETA OR IL-6 DURING ACTIVATION-INDUCED BY PARAFORMALDEHYDE-TREATED LANGERHANS CELLS, Journal of cellular biochemistry, 1995, pp. 27-27
Authors:
DESQUEPER BG
GILLES JG
JACQUEMIN MG
DIGIAMBATISTA M
LAUB R
SAINTREMY JM
Citation: Bg. Desqueper et al., COHNS FRACTIONS AS A SOURCE OF ANTI-FACTOR-VIII AND CORRESPONDING ANTIIDIOTYPIC ANTIBODIES FOR POSSIBLE THERAPEUTIC PURPOSES OF HEMOPHILIA-A PATIENTS WITH INHIBITORS, Thrombosis and haemostasis, 73(6), 1995, pp. 1011-1011
Authors:
SCHNEEBERGER A
KUTIL R
KOSZIK F
LAUB R
BUSCHLE M
WAGNER E
BIRNSTIEL M
STINGL G
Citation: A. Schneeberger et al., IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS OVERCOMES TUMOR-INDUCED IMMUNOSUPPRESSION, Journal of investigative dermatology, 104(4), 1995, pp. 681-681
Citation: R. Laub et al., FUNCTIONAL-SIGNIFICANCE OF LANGERHANS CELL-DERIVED IL-1-BETA AND IL-6FOR THE INITIATION OF PRIMARY ALLOGENEIC T-CELL RESPONSES, Journal of investigative dermatology, 102(4), 1994, pp. 526-526